The Novina Lab received a notice of award for the NIDDK Catalyst award (DP1 mechanism) to study lncRNAs involved in browning of white fat.
|
The Novina Lab began work on a sponsored research agreement with Atossa Genetics using nanoparticles to reprogram the tumor microenvironment.
Alberto Nobili, Scientist I at Dana-Farber, becomes a Scientific Director at Raqia Therapeutics. Alberto developed the BAT-CAR technology while in the Novina Lab and will lead an effort to translate this technology to benefit patients with cancers.
Bob Distel, Special Advisor and Technology Specialist, formally joined our lab. Bob has been a close Novina Lab collaborator for years, while he worked in BODFI.
Steven Neier, Scientist I at Dana-Farber, accepted a new position with a Dana-Farber Venture Fund called Binney Street Capital, a newly-created fund using the Dana-Farber endowment.
|
Novina Lab NewsArchives
July 2021
Categories
|
RSS Feed